Digitalized Pharma

Co-Innovating Transformation with LTTS

Digitalized PharmaContents

Thank you for reading Digitalized Pharma

STATE OF
THE MARKET

Incremental changes and sustainable transformation initiatives are redefining the global healthcare and life sciences landscape. We are witnessing a definite shift from the legacy fee-for-service paradigm to more state-of-art models – driving new frontiers in patient-centric, value-based solutions.

CHALLENGES

However, the transition is not without its share of associated challenges. For the global Pharma and Clinical Research industry, this involves:

Addressing higher operational costs – Legacy R&D models continue to be somewhat of a "productivity pain point" within pharmaceutical organizations. While high research costs drive up expectations for higher productivity and reliability, pharmaceutical companies must provide consistently high quality at a lower cost. The scenario is complicated by continuous maintenance and upgradation requirements, mainly around the need for accurate calibration of plant and equipment.
Rethinking productivity paradigms – Increasing competition, changing regulatory requirements, disruptive technologies, and various other factors are driving pharmaceutical manufacturers to fast-track innovation to boost their productivity while maintaining product quality.
Improving quality and compliance – Pharmaceutical manufacturers worldwide are facing compliance challenges across emerging markets —especially in terms of culturally distinct ideas about safety, risk, and quality – along with the ongoing need to address drug shortages, secure storage, and data sharing.
Accelerating scientific breakouts – Rapid drug discovery processes are critical for dealing with new viral outbreaks and epidemics, such as COVID-19. A supplier-side CoE can play a vital role in this direction.
Enhancing research efficiency – The power of artificial intelligence algorithms and solutions to make the most of big data and test hypotheses with quantum computing is the need of the hour. This could have a transformative impact on manpower utilization, process compliance, device design, logistical challenges, and the handling of biohazard drugs.
Co-creating innovation – Clinical Research Organizations and pharmaceutical companies need to allocate scarce resources for handling their innovation workload – benchmarking technologies across scenarios and integrating them to operationalize and monetize the outcomes. A robust and reliable partner ecosystem is necessary for driving a co-creation innovation engine for continued business success.

Access to state-of-the-art tools and facilities, cutting-edge services, and the expertise to achieve targets in the stipulated time is therefore vital for engineering new products and managing existing offerings.

LTTS’ OFFERINGS

Our Team of Engineers are active across the value chain, covering:

KEY DIFFERENTIATORS

SUCCESS SNIPPETS

Helping life sciences companies provide more informed, connected patient support.

Accelerating adoption is a top priority for biopharma organizations.

Reimagine clinical development by leveraging a cloud-enabled suite and real-world data to power patient-centric design. We helped the company quickly compile and submit safety and efficacy data in a digital format for sleep-related clinical trials.

Cloud-Enabled Solutions for Lifesciences companies
A leading pharma company wanted to dynamically synthesize metrics from the health and survey data and monetize these data metrics.

LTTS clinical data cloud provided one unified platform for all your clinical data from acquisition through analytics. The solution brings a cloud-native, insight-driven approach that enables companies to manage internal and external clinical trial data.

Continuous blood glucose monitoring
We developed a solution across various domains – mobile, web application development, data security,and application testing to deliver end to end patient-centric solution.

Scan here to know more about Our Pharma and CRO Capabilities